Efficacy of aflibercept for Macular edema secondary to central retinal vein occlusion (CRVO)
Not Applicable
Recruiting
- Conditions
- central retinal vein occlusion
- Registration Number
- JPRN-UMIN000014505
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) The following exclusions apply to the study eye only. Prior treatment with steroids (<3 months) History of vitrectomy surgery, submacular surgery, or other surgical intervention. 2) Active intraocular inflammation. 3) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products, or to any of the study drugs or their components. 4) pregnant women and nursing mothers. 5) Patient who the doctor in charge judges are ineligible for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VA change from baseline to month 12 Change of retinal thickness, chroidal thickness and edema from baseline to month 12
- Secondary Outcome Measures
Name Time Method